INNT
TOTAL INVALIDATION PROCESSED BY THE IB
16/05/2025
Voltar para busca
Dado oficial do USPTO
CENTOBREAST
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CENTOBREAST
ST13
US500000079193468Classe
5, 42, 44
Pedido
79193468
Registro
5337452
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
17/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
11/03/2016
Data de registro
21/11/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/06/2024
Última transação
17/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
DE
Examinador
SEVERSON, JUSTIN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Centogene GmbH
Centogene AG
Representantes
Angela P. Doughty Ward and Smith, P. A.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparationstreated or untreated human biological specimens; Pharmaceutical and veterinary preparationspreparations for treatment with stabilizers that prevent degradation of nucleic acids; pharmaceutical and veterinary preparations comprising treated or untreated human biological specimensstabilizers preventing degradation of nucleic acids; chemical preparations for analyses in laboratoriesfor medical or veterinary purposesisolation and processing of nucleic acidswith chemicalsoligonucleotides and reagents for downstream sequencingchemical preparations comprising treated or untreated human biological specimens comprising isolated and/or processes nucleic acidsoptionally chemical compoundsoligonucleotides and/or reagents for downstream sequencing; cultures of microorganisms for medical and veterinary use; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; biological preparations for medical purposesfor the treatment of hereditary diseasesoncological diseases and complex multigenic diseases; preparations for detecting genetic predispositions for medical purposes; nucleic acid sequences for medical and veterinary purposes
Classe 42
Scientific and technological servicesscientific researchanalysis and testing in the field of oncological diseaseshereditary diseases and complex multigenic diseases; industrial analysis and research services in the field of oncological diseaseshereditary diseases and complex multigenic diseases; scientific research for medical purposes in the field of oncological diseaseshereditary diseases and complex multigenic diseases; research and development in the field of biotechnology; genetic engineering services; research and development in the field of diagnostics; design and development of medical diagnostic apparatus; design and development of computer hardwarecomputer software and databases; computer aided scientific research servicestesting and analysis services
Classe 44
Medical and veterinary servicesin particular medical analysis in connection with the treatment of individuals; conducting of medical tests for diagnostic or treatment purposes; medical laboratory services for the analysis of samples taken from patientsmedical testing of bloodtissuesalivaurinelymph fluidliquorstool and hair follicle; providing information in the fields of medicineveterinary medicine and pharmacology
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
26/04/2025
INPC
INVALIDATION PROCESSED
26/04/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/02/2025
C71T
CANCELLED SECTION 71
07/06/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21/11/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/09/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/07/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/04/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/02/2018
FIMP
FINAL DISPOSITION PROCESSED
22/02/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
21/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2017
PUBO
PUBLISHED FOR OPPOSITION
05/09/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/07/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
31/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
31/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
31/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
31/07/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/06/2017
GNRT
NON-FINAL ACTION E-MAILED
08/06/2017
CNRT
NON-FINAL ACTION WRITTEN
08/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/05/2017
ALIE
ASSIGNED TO LIE
17/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/04/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/11/2016
RFNT
REFUSAL PROCESSED BY IB
18/11/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/10/2016
RFRR
REFUSAL PROCESSED BY MPU
28/10/2016
MAFR
APPLICATION FILING RECEIPT MAILED
22/10/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/10/2016
CNRT
NON-FINAL ACTION WRITTEN
18/10/2016
DOCK
ASSIGNED TO EXAMINER
18/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/10/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/10/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CENTOBREAST ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.